NCT05956145View on ClinicalTrials.gov

Effect of Low Dose of Colchicine on Platelet Reactivity

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

June 17, 2021

Primary Completion Date

April 3, 2024

Study Completion Date

April 3, 2024

Conditions
Platelet Aggregation, SpontaneousCoronary Artery Disease
Interventions
DRUG

Colchicine 0.5 MG

Patients with proven chronic coronary disease (documented by a previous history of AMI with or without ST-segment elevation) will be randomized to receive colchicine 0.5 mg once daily (intervention group) or placebo (control group) for a period of 30 ± 3 days.

OTHER

Placebo

Patients with proven chronic coronary disease (documented by a previous history of AMI with or without ST-segment elevation) will be randomized to receive colchicine 0.5 mg once daily (intervention group) or placebo (control group) for a period of 30 ± 3 days.

Trial Locations (1)

05403-000

Heart Institute (InCor) / University of São Paulo, São Paulo

All Listed Sponsors
lead

University of Sao Paulo

OTHER